Originally approved by the FDA in 2017 as a weekly injection to lower blood sugar under the name Ozempic, semaglutide was later approved in 2019 as a tablet form called Rybelsus to treat diabetes
Do not reuse a needle
Cost Considerations and Medication Access Managing both diabetes and high blood pressure can involve multiple medications, making cost a significant concern for many patients
Other Ingredients: Dicalcium phosphate, microcrystalline cellulose, stearic acid, magnesium stearate, croscarmellose sodium, aqueous film coating (purified water, hydroxypropyl methylcellulose, polyethylene glycol) This product contains NO animal products, soy, wheat, yeast, salt, gluten, sugar, milk, artificial flavors, colorings or preservatives
These can include: Abdominal cramping Bloating A feeling of fullness These effects are usually temporary and often resolve as the body adjusts to the supplement